Literature DB >> 33124741

Recommended dose voxel size and statistical uncertainty parameters for precision of Monte Carlo dose calculation in stereotactic radiotherapy.

Simon K Goodall1,2, Martin A Ebert1,3,4.   

Abstract

Monte Carlo (MC)-based treatment planning requires a choice of dose voxel size (DVS) and statistical uncertainty (SU). These parameters effect both the precision of displayed dose distribution and time taken to complete a calculation. For efficient, accurate, and precise treatment planning in a clinical setting, optimal values should be selected. In this investigation, 30 volumetric modulated arc therapy (VMAT) stereotactic radiotherapy (SRT) treatment plans, 10 brain, 10 lung, and 10 spine were calculated in the Monaco 5.11.02 treatment planning system (TPS). Each plan was calculated with a DVS of 0.1 and 0.2 cm using SU values of 0.50%, 0.75%, 1.00%, 1.50%, and 2.00%, along with a ground truth calculation using a DVS of 0.1 cm and SU of 0.15%. The variance at each relative dose level was calculated for all SU settings to assess their relationship. The variation from the ground truth calculation for each DVS and SU combination was determined for a range of DVH metrics and plan quality indices along with the time taken to complete the calculations. Finally, the effect of defining the maximum dose using a volume of 0.035 cc was compared to 0.100 cc when considering DVS and SU settings. Changes in the DVS produced greater variations from the ground truth calculation than changes in SU across the values tested. Plan quality metrics and mean dose values showed less sensitivity to changes in SU than DVH metrics. From this study, it was concluded that while maintaining an average calculation time of <10 min, 75% of plans could be calculated with variations of <2.0% from their ground truth values when using an SU setting of 1.50% and a DVS of 0.1 cm in the case of brain or spine plans, and a 0.2 cm DVS in the case of lung plans.
© 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.

Entities:  

Keywords:  Monte Carlo; stereotactic radiotherapy; treatment planning

Mesh:

Year:  2020        PMID: 33124741      PMCID: PMC7769395          DOI: 10.1002/acm2.13077

Source DB:  PubMed          Journal:  J Appl Clin Med Phys        ISSN: 1526-9914            Impact factor:   2.102


  25 in total

1.  Towards the elimination of Monte Carlo statistical fluctuation from dose volume histograms for radiotherapy treatment planning.

Authors:  J Sempau; A F Bielajew
Journal:  Phys Med Biol       Date:  2000-01       Impact factor: 3.609

2.  A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note.

Authors:  I Paddick
Journal:  J Neurosurg       Date:  2000-12       Impact factor: 5.115

3.  Investigation of variance reduction techniques for Monte Carlo photon dose calculation using XVMC.

Authors:  I Kawrakow; M Fippel
Journal:  Phys Med Biol       Date:  2000-08       Impact factor: 3.609

4.  Dose variations with varying calculation grid size in head and neck IMRT.

Authors:  Heeteak Chung; Hosang Jin; Jatinder Palta; Tae-Suk Suh; Siyong Kim
Journal:  Phys Med Biol       Date:  2006-09-14       Impact factor: 3.609

Review 5.  Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning.

Authors:  Indrin J Chetty; Bruce Curran; Joanna E Cygler; John J DeMarco; Gary Ezzell; Bruce A Faddegon; Iwan Kawrakow; Paul J Keall; Helen Liu; C M Charlie Ma; D W O Rogers; Jan Seuntjens; Daryoush Sheikh-Bagheri; Jeffrey V Siebers
Journal:  Med Phys       Date:  2007-12       Impact factor: 4.071

6.  BEAM: a Monte Carlo code to simulate radiotherapy treatment units.

Authors:  D W Rogers; B A Faddegon; G X Ding; C M Ma; J We; T R Mackie
Journal:  Med Phys       Date:  1995-05       Impact factor: 4.071

Review 7.  ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery.

Authors:  Lotte Wilke; Nicolaus Andratschke; Oliver Blanck; Thomas B Brunner; Stephanie E Combs; Anca-Ligia Grosu; Christos Moustakis; Daniela Schmitt; Wolfgang W Baus; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2019-01-16       Impact factor: 3.621

8.  Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice.

Authors:  Arjun Sahgal; Vivian Weinberg; Lijun Ma; Eric Chang; Sam Chao; Alexander Muacevic; Alessandra Gorgulho; Scott Soltys; Peter C Gerszten; Sam Ryu; Lilyana Angelov; Iris Gibbs; C Shun Wong; David A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-17       Impact factor: 7.038

Review 9.  Estimated Risk Level of Unified Stereotactic Body Radiation Therapy Dose Tolerance Limits for Spinal Cord.

Authors:  Jimm Grimm; Arjun Sahgal; Scott G Soltys; Gary Luxton; Ashish Patel; Scott Herbert; Jinyu Xue; Lijun Ma; Ellen Yorke; John R Adler; Iris C Gibbs
Journal:  Semin Radiat Oncol       Date:  2016-01-04       Impact factor: 5.934

10.  AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams.

Authors:  Jennifer B Smilowitz; Indra J Das; Vladimir Feygelman; Benedick A Fraass; Stephen F Kry; Ingrid R Marshall; Dimitris N Mihailidis; Zoubir Ouhib; Timothy Ritter; Michael G Snyder; Lynne Fairobent
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

View more
  2 in total

1.  Maintaining dosimetric quality when switching to a Monte Carlo dose engine for head and neck volumetric-modulated arc therapy planning.

Authors:  Vladimir Feygelman; Kujtim Latifi; Mark Bowers; Kevin Greco; Eduardo G Moros; Max Isacson; Agnes Angerud; Jimmy Caudell
Journal:  J Appl Clin Med Phys       Date:  2022-02-25       Impact factor: 2.243

2.  A phase space model of a Versa HD linear accelerator for application to Monte Carlo dose calculation in a real-time adaptive workflow.

Authors:  James L Bedford; Rahul Nilawar; Simeon Nill; Uwe Oelfke
Journal:  J Appl Clin Med Phys       Date:  2022-06-14       Impact factor: 2.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.